HEAL Initiative: NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required)
The summary for the HEAL Initiative: NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
HEAL Initiative: NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required): The purpose of this NOFO is to solicit UG3/UH3 phased award research applications to conduct efficient, large-scale pragmatic clinical trial and/or implementation science Demonstration Projects within the infrastructure of the NIH-DoD-VA Pain Management Collaboratory (PMC) on non-opioid approaches to pain management and other comorbid conditions in U.S. veterans, military personnel, and their families. Additional emphasis on a whole person approach to pain management will be added as a priority for NCCIH and partnering ICOs will also add their priority areas that include pain. This NOFO will add a trial supported by the HEAL Initiative, an NIH-wide research effort aimed at addressing the opioid epidemic in part by identifying effective, non-opioid pain management solutions. The PMC established a Coordinating Center in 2017 that provides national leadership and technical expertise for all aspects of PMC research including assistance to Demonstration Project grant awardees.
Federal Grant Title: | HEAL Initiative: NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AT-24-011 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.213, 93.273, 93.866 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | November 7th, 2024 |
Original Application Deadline: | November 7th, 2024 |
Posted Date: | August 9th, 2024 |
Creation Date: | August 9th, 2024 |
Archive Date: | December 13th, 2024 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | August 9th, 2024 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-24-011.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- • Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Organiza...
- • NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented ...
- • NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientis...
- • NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientis...
- • Probiotics for Pediatric Illnesses
- • Cam Practitioner Research Education Project Grant Partnership
- • Complementary and Alternative Medicine Career Transition Award (K22)
- More Grants from the National Institutes of Health
- • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
- • Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
- • Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Inc...
- • Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Tri...
- • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...